A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor-Positive Breast Cancer: The BRACELET-01/PrE0113 Study. - Clark AS; Zhao F; Klein P; Montero AJ; Falkson C; Krill-Jackson E; Rowland K; Sardesai S; Incorvati J; Dillon P; Wolff AC; Trauger R; et al. (Clinical cancer research : an official journal of the American Association for Cancer Research, 2025)